Onconetix
(NASDAQ) BWV
Onconetix Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$815.37K
Net Income (TTM)
$14.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BWV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Onconetix
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Karina M. Fedasz, MBA, CPA
Website
www.onconetix.comHeadquarters
Cincinnati, OH 45202, US
BWV Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
-22%
Net Income Margin
-17%
Return on Equity
-2%
Return on Capital
-1%
Return on Assets
-56%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-2.92%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$632.91K
Operating Income
$17.86M
EBITDA
$17.86M
Operating Cash Flow
$9.68M
Capital Expenditure
$0.00
Free Cash Flow
$9.68M
Cash & ST Invst.
$5.22M
Total Debt
$48.77K
Onconetix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$303.60K
-78.5%
Gross Profit
$247.68K
-70.8%
Gross Margin
81.58%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
12
N/A
Net Income
$5.67M
+116.1%
EBITDA
$5.02M
+113.6%
Quarterly Fundamentals
Net Cash
$5.17M
+158.8%
Accounts Receivable
$296.87K
+1054.4%
Inventory
$149.96K
+134.0%
Long Term Debt
$24.36K
N/A
Short Term Debt
$24.41K
-99.7%
Return on Assets
-56.29%
N/A
Return on Invested Capital
-1.13%
N/A
Free Cash Flow
$3.09M
+50.8%
Operating Cash Flow
$3.09M
+51.0%